IDNA Genomics Public Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	0.01	0.41	0.1
Cash & Short-Term Investments	0.01	0.41	0.1
Cash Growth	-97.08%	286.37%	-
Accounts Receivable	0.44	0.14	0.12
Other Receivables	-	0.33	0.23
Receivables	0.44	0.47	0.35
Inventory	0.3	0.26	0.21
Total Current Assets	0.75	1.13	0.66
Property, Plant & Equipment	0.34	0.35	0.42
Long-Term Investments	-	0.1	3.85
Goodwill	-	-	1.34
Other Intangible Assets	-	1.23	1.22
Long-Term Accounts Receivable	0.04	-	-
Long-Term Deferred Tax Assets	0	0	0
Other Long-Term Assets	-	0.05	0.03
Total Assets	1.14	2.86	7.52
Accounts Payable	2.42	0.44	1.37
Accrued Expenses	-	0.07	0.06
Short-Term Debt	1.43	1.48	0.22
Current Portion of Leases	0.16	0.12	0.11
Other Current Liabilities	-	0.3	0.53
Total Current Liabilities	4.01	2.41	2.29
Long-Term Debt	1.22	0.98	2.64
Long-Term Leases	0.11	0.14	0.19
Long-Term Deferred Tax Liabilities	-	0	-
Other Long-Term Liabilities	0.01	-	-
Total Liabilities	5.35	3.52	5.12
Common Stock	0.03	0.03	0.03
Additional Paid-In Capital	3.85	3.85	3.85
Retained Earnings	-3.15	-0.91	-1.47
Comprehensive Income & Other	-3.83	-3.75	-
Total Common Equity	-3.11	-0.79	2.4
Minority Interest	-1.1	0.12	-
Shareholders' Equity	-4.21	-0.66	2.4
Total Liabilities & Equity	1.14	2.86	7.52
Total Debt	2.92	2.71	3.15
Net Cash (Debt)	-2.91	-2.31	-3.05
Net Cash Growth	-	-	-
Net Cash Per Share	-1.05	-0.84	-1.10
Filing Date Shares Outstanding	2.76	2.76	2.76
Total Common Shares Outstanding	2.76	2.76	2.76
Working Capital	-3.25	-1.27	-1.63
Book Value Per Share	-1.13	-0.28	0.87
Tangible Book Value	-3.11	-2.02	-0.15
Tangible Book Value Per Share	-1.13	-0.73	-0.06
Machinery	-	0.19	0.18